3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
2
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
3977
Pancreatic Neoplasms
2478
Carcinoma, Hepatocellular
2411
Stomach Neoplasms
2108
Rectal Neoplasms
1676
Colonic Neoplasms
1629
Esophageal Neoplasms
1311
Liver Neoplasms
878
Neoplasms
633
Breast Neoplasms
596
Cholangiocarcinoma
525
Gastrointestinal Neoplasms
468
Neoplasm Metastasis
456
Esophageal Squamous Cell Carcinoma
434
Lung Neoplasms
422
Biliary Tract Neoplasms
277
Prostatic Neoplasms
270
Ovarian Neoplasms
235
Barrett Esophagus
224
Adenocarcinoma Of Esophagus
202
Gallbladder Neoplasms
191
Head and Neck Neoplasms
185
Carcinoma, Non-Small-Cell Lung
185
Gastrointestinal Stromal Tumors
180
Anus Neoplasms
179
Recurrence
168
Melanoma
162
Adenocarcinoma
156
Uterine Cervical Neoplasms
153
Bile Duct Neoplasms
153
Interventions
beta Carotene
1
Vitamin E
1
Geritol
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Eye Diseases
×
Gastrointestinal
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled